XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
OVERLAYS
Fund
Benchmark
3Y · NAV total return · GBP
Biotech: holdings, performance and fees
1Y return+63.6%
3Y return+88.3%
5Y return+60.1%
OCF (ongoing charge)1.99%
Top 10 holdings
| Holding | Weight |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 5.1% |
| Insmed Inc Ord | 5.0% |
| ARGENX SE | 4.5% |
| REVOLUTION MEDICINES INC | 4.3% |
| BIOGEN INC. | 3.5% |
| AMGEN INC. | 3.4% |
| ROIVANT SCIENCES LTD. | 3.4% |
| BRIDGEBIO PHARMA, INC. | 2.9% |
| IONIS PHARMACEUTICALS, INC. | 2.7% |
| CYTOKINETICS, INCORPORATED | 2.5% |
Top sectors
- Biotechnology/Medical100.0%
Top countries
- International100.0%
Holdings, sector and country weightings and performance as reported by FE fundinfo. Weightings are a percentage of the portfolio and may not sum to 100.
AI FORECAST · 12-MONTH
Powered by Claude
FREE PREVIEW
Sign up free to unlock the full AI analysis →
UP—
PREMIUM
PREMIUM
Positives
Risks
600 adviser votes
Upgrade for full forecast →
This is an illustrative, model-generated scenario based on stated assumptions. It is not a prediction, a forecast of actual returns, or investment advice. Outcomes may differ materially. Past performance is not a guide to future returns. Capital is at risk.
PORTFOLIO BREAKDOWN